RGNX

RGNX

USD

REGENXBIO Inc. Common Stock

$11.560+0.140 (1.226%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$11.420

Máximo

$11.955

Mínimo

$11.375

Volume

0.20M

Fundamentos da empresa

Capitalização de mercado

583.9M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.60M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $5.035Atual $11.560Máximo $13.925

Notícias relacionadas

PR Newswire

REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program

REGENXBIO Inc. (Nasdaq: RGNX) today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational...

Ver mais
REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
PR Newswire

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial...

Ver mais
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
PR Newswire

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan's 9th Annual Genetic Medicines...

Ver mais
REGENXBIO to Participate in Upcoming Investor Conferences

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.